SecBot SecBot
8-K ·Filed Jun 2, 2026

CTKB

Cytek Biosciences, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago SEC0001193125-26-253538
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for the appointment of a new SVP of Global Sales and Services, as the role is critical to revenue generation. The resignation appears amicable, but any delay in filling the position could signal organizational challenges.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CTKB ▲ +14.07% at T+60d
NEUTRAL call +14.07% · α vs SPY +11.58% · entry $4.05 → $4.62
Entry = T+0 close
Jun 2, 2026
via day close
T+1d
+6.91%
call +6.91% · α +6.51%
$4.33
settled 5mo ago
T+5d
0.00%
call 0.00% · α +3.82%
$4.05
settled 5mo ago
T+20d
+13.33%
call +13.33% · α +14.33%
$4.59
settled 4mo ago
T+60d
+14.07%
call +14.07% · α +11.58%
$4.62
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Cytek Biosciences disclosed the resignation of Philippe Busque, Ph.D., Senior Vice President of Global Sales and Services, effective June 5, 2026, to pursue another career opportunity. The filing explicitly states the resignation is not due to any disagreement with the company's operations, policies, or practices, and no replacement has been named.

Key Facts

  • Philippe Busque, Ph.D., SVP of Global Sales and Services, resigned effective June 5, 2026.
  • Resignation is for another career opportunity, not due to any disagreement with company operations.
  • No replacement has been named in the filing.

Financial Impact

No financial figures disclosed; departure of a senior sales executive may have minor operational impact.

Risk Factors

  • Potential disruption to global sales operations if a replacement is not named promptly.
  • Possible negative sentiment if the departure is followed by further executive turnover.

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-253538
Document: 0001193125-26-253538-index-headers.html0001193125-26-253538
Document: 0001193125-26-253538-index.html0001193125-26-253538
Document: 0001193125-26-253538.txt0001193125-26-253538
8 reports for CTKB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CTKB — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$5.43awaiting T+20—$5.89 (+8.47%)
Sep 22, 2026
4w ago
Institutional Cluster
MIXED ★ 4/10
$5.71 $5.34▼ −6.48%▼ −5.92%$5.89 (+3.15%)
Aug 24, 2026
9w ago
8-K
BEARISH ★ 7/10
$4.44 $5.71▼ −28.60%▼ −27.29%$5.89 (−32.66%)
Jun 25, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$4.48 $4.56▲ +1.79%▲ +0.53%$5.89 (+31.47%)
Jun 12, 2026
19w ago
3
NEUTRAL ★ 2/10
$3.93 $4.51▲ +14.76%▲ +15.51%$5.89 (+49.87%)
Jun 11, 2026
19w ago
Institutional Cluster
BEARISH ★ 5/10
$4.02 $4.59▼ −14.18%▼ −12.29%$5.89 (−46.52%)
Jun 2, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$4.05 $4.59▲ +13.33%▲ +14.33%$5.89 (+45.43%)
Apr 28, 2026
25w ago
DEFA14A
NEUTRAL ★ 2/10
$4.44 $4.12▼ −7.21%▼ −13.26%$5.89 (+32.66%)
Showing 8 of 8

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026